EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cerebral small vessel injury in mice with damage to ACE2‐expressing cerebral vascular endothelial cells and post COVID‐19 patients

Jieping Lu, Xin Zuo, Aoling Cai, Fang Xiao, Zhenyu Xu, Rui Wang, Chenjian Miao, Chen Yang, Xingxing Zheng, Jie Wang, Xiaoling Ding, Wei Xiong

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.14279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Jieping Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China…. Hauptthemen laut MEDLINE: COVID-19, Angiotensin-Converting Enzyme 2, Cerebral Small Vessel Diseases, Endothelial Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, the Strategic Priority Research Program of the Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The angiotensin‐converting enzyme 2 (ACE2), which is expressed in cerebral vascular endothelial cells (CVECs), has been currently identified as a functional receptor for SARS‐CoV‐2. METHODS We specifically induced injury to ACE2‐expressing CVECs in mice and evaluated the effects of such targeted damage through magnetic resonance imaging (MRI) and cognitive behavioral tests. In parallel, we recruited a single‐center cohort of COVID‐19 survivors and further assessed their brain microvascular injury based on cognition and emotional scales, cranial MRI scans, and blood proteomic measurements. RESULTS Here, we show an array of pathological and behavioral alterations characteristic of cerebral small vessel disease (CSVD) in mice that targeted damage to ACE2‐expressing CVECs, and COVID‐19 survivors. These CSVD‐like manifestations persist for at least 7 months post‐recovery from COVID‐19. DISCUSSION Our findings suggest that SARS‐CoV‐2 may induce cerebral small vessel damage with persistent sequelae, underscoring the imperative for heightened clinical vigilance in mitigating or treating SARS‐CoV‐2‐mediated cerebral endothelial injury throughout infection and convalescence. Highlights Cerebral small vessel disease–associated changes were observed after targeted damage to angiotensin‐converting enzyme 2–expressing cerebral vascular endothelial cells. SARS‐CoV‐2 may induce cerebral small vessel damage with persistent sequelae. Clinical vigilance is needed in preventing SARS‐CoV‐2–induced cerebral endothelial damage during infection and recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Angiotensin-Converting Enzyme 2Cerebral Small Vessel DiseasesEndothelial CellsSARS-CoV-2AnimalsMiceHumansMaleFemaleMagnetic Resonance ImagingMiddle AgedAgedBrainDisease Models, Animal

Stichwörter der Autor:innen

COVID‐19 convalescentangiotensin‐converting enzyme 2cerebral small vessel diseasecerebral small vessels impairmentcerebral vascular endothelial cells

Substanzen

Angiotensin-Converting Enzyme 2Ace2 protein, mouseACE2 protein, human

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Anhui Province Key Laboratory of Biomedical Imaging and Intelligent Processing, Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, Hefei, China.
  • Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Ma…
  • The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou Second People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, China.
  • Department of Radiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • University of Chinese Academy of Sciences, Beijing, China.

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • the Strategic Priority Research Program of the Chinese Academy of Sciences
  • Key Research Program of Frontier Science
  • CAS Interdisciplinary Innovation Team
  • Youth Innovation Promotion Association CAS
  • USTC Research Funds of the Double First-Class Initiative
  • CAS Project for Young Scientists in Basic Research

Zitieren

APA

Lu, J., Zuo, X., Cai, A., Xiao, F., Xu, Z., Wang, R., Miao, C., Yang, C., Zheng, X., Wang, J., Ding, X., & Xiong, W. (2024). Cerebral small vessel injury in mice with damage to ACE2‐expressing cerebral vascular endothelial cells and post COVID‐19 patients. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14279

Vancouver

Lu J, Zuo X, Cai A, Xiao F, Xu Z, Wang R, et al. Cerebral small vessel injury in mice with damage to ACE2‐expressing cerebral vascular endothelial cells and post COVID‐19 patients. Alzheimer's & Dementia. 2024. doi:10.1002/alz.14279

BibTeX
@article{Lu2024,
  author = {Lu, Jieping and Zuo, Xin and Cai, Aoling and Xiao, Fang and Xu, Zhenyu and Wang, Rui and Miao, Chenjian and Yang, Chen and Zheng, Xingxing and Wang, Jie and Ding, Xiaoling and Xiong, Wei},
  title = {Cerebral small vessel injury in mice with damage to ACE2‐expressing cerebral vascular endothelial cells and post COVID‐19 patients},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.14279}
}
Kostenlos starten →